...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Cristina Signes

Cristina Signes

Verified

Dr. Cristina Signes Pon is a specialist in Obstetrics and Gynecology Colegiado Number : 464623236 Clinical interests: General Gynaecology, Pelvic Floor Dysfunction, Urinary and Gynaecological Related Bowel Dysfunction, Pelvic Floor related Sexual Dysfunction, Urogynaecology, Specialist in Obstetrics and Gynecology. Dr. Cristina Signes Pons is a highly respected gynecologist with over a decade of experience, specializing in Obstetrics and Gynecology. After earning her medical degree from the prestigious University of Valencia in 2012, she completed her specialized residency training at the University and Polytechnic Hospital La Fe de Valencia in 2017. Dr. Signes is an active member of the Ilustre Colegio Oficial de Médicos de Valencia, with license number 464623236. With clinics in both Moraira and Javea and ongoing work at Denia Hospital, Dr. Signes has become a trusted name in women's healthcare throughout the region. Known for her compassionate approach, she offers personalized sexual health screenings and expert care in Gynecology, ensuring each patient feels comfortable and supported. She is also specially trained in delivering the cutting-edge NU-V treatment, offering innovative solutions tailored to individual needs. Whether it’s general gynecological care, maternity services, or specialized treatments, Dr. Cristina Signes Pons is dedicated to helping her patients make informed and empowered health decisions.

MD OB-GYN
Was this answer helpful?
Rate Cristina's explanation
0.0 (5)
womens health clinic faq



Diagnosis first


Long-term care


Vulval skin safety

Women’s Health Clinic FAQ

Does lichen sclerosus affect sexual intercourse?

Lichen sclerosus questions deserve a calm answer because symptoms can be intimate, persistent and easily mistaken for thrush, dryness or irritation.

Direct answer

Lichen sclerosus can affect sexual intercourse through pain, fissures, scarring, narrowing, dryness, fear of tearing and emotional strain. Treatment aims to control skin disease and support comfort, not promise sexual outcomes.

The safest page separates symptom relief from disease control, explains when review matters, and avoids implying that self-care or adjunctive treatments replace prescribed care.


Educational only. Suitability and next steps should be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation about does lichen sclerosus affect sexual intercourse?

Vulval skin care

At a glance

These are the main points to understand before deciding what care or treatment pathway is appropriate.

At a glance

Practical clinical summary

Main area

Vulval skin

Care pattern

Ongoing care

Watch for

Skin change

Next step

Planned follow-up

Important safety note

Symptoms in intimate areas should not be self-diagnosed from appearance alone. Assessment helps separate inflammation, low-oestrogen change, infection, pelvic-floor symptoms and skin conditions.

Assessment
Symptoms
Treatment options
Red flags
Follow-up




Detailed answer

Detailed answer

The deeper answer depends on matching the symptom to the right tissue and diagnosis. That is especially important when online pages blur vulval skin, vaginal tissue, prolapse and sexual discomfort.

Pain and fissures

The reader wants a sensitive explanation of sex, libido, pain, tearing and intimacy with LS.

Cause
Diagnosis
Treatment
Review

Pain and fissures

This is the first distinction to make because it shapes whether advice is about skin care, vaginal tissue, pelvic floor or specialist referral.

Scarring and narrowing

Symptoms should be interpreted alongside timing, severity, visible change, treatment history and whether the problem is new or worsening.

Dryness and lubrication

Treatment choices should be presented as options to discuss, not as a single automatic pathway.

Emotional and relationship effects

Follow-up matters when symptoms persist, recur, alter skin architecture or affect sex, urination, exercise or daily comfort.

How the research shapes the answer

Maintenance Needs: Long-term, intermittent use of topical steroids (e.g., twice weekly maintenance) is required to control symptoms and halt architectural destruction without causing skin thinning. Alternative Therapies: For persistent or complicated cases, treatments may.

The benchmark structure was used for search intent, but the final wording is deliberately more cautious than promotional clinic pages.





Patient safety

Why this distinction matters

Many intimate-health symptoms sound similar online, but the safest treatment plan depends on the underlying cause.

It avoids missed diagnosis

Itching, burning, dryness, pain or white skin change can point to different conditions that need different care.

It protects treatment choice

Supportive measures, prescribed treatment, device-based care and referral each have different roles.

It keeps expectations realistic

Some treatments support comfort or symptoms, but they may not reverse scarring, repair prolapse or remove the need for monitoring.

It supports safer follow-up

Persistent, worsening or changing symptoms should be reviewed rather than repeatedly self-managed.

Calm, practical care

A strong page should help patients understand what may be common, what needs review and what questions to bring to consultation.

It should validate symptoms without turning normal variation or manageable conditions into fear.





Considerations

What to consider

Application: Steroid ointments should be applied sparingly (a 0.5g fingertip unit) only to affected skin areas. Quantities: A standard 30g tube of Clobetasol propionate should last about 12 weeks during initial treatment. Maintenance aims.

Consultation priorities

The consultation should clarify symptoms, anatomy, medical history, medicines, menopause or cancer-treatment context, previous treatments and any skin changes.

History
Examination
Options
Follow-up

Before treatment

Confirm whether symptoms are due to vulval skin disease, vaginal atrophy, infection, pelvic-floor change, prolapse or another cause.

Treatment boundaries

Device treatments, complementary therapies and self-care should not be presented as substitutes for diagnosis or prescribed treatment.

Ongoing care

Long-term symptoms may need maintenance care, flare planning, skin checks or review with a specialist service.

If symptoms change

New bleeding, ulcers, urinary problems, severe pain or visible skin change should be assessed promptly.

What not to assume

Do not assume every intimate symptom is thrush, menopause, laxity or a cosmetic problem.

Costs, treatment course and suitability should be confirmed through WHC guidance or consultation rather than competitor claims.





Common concerns and myths

Common misconceptions

Online advice can make intimate symptoms sound simpler than they are. These corrections keep the page clinically safer.

Myth: Pain during sex is only psychological

Reality: assessment is needed before deciding whether this applies to your symptoms.

Myth: LS means sex must stop forever

Reality: symptom control, tissue care and long-term review can be separate issues.

Myth: Lubricant alone treats LS pain

Reality: supportive measures may help comfort, but they should not delay appropriate medical review.

Diagnosis comes first

The same symptom can come from skin inflammation, low-oestrogen change, infection, pelvic-floor guarding or prolapse.

Treatment should be proportionate

A safe plan may include reassurance, skin care, prescribed treatment, physiotherapy, device treatment or specialist referral depending on the diagnosis.





Safety checklist

Safety checklist

Use these checks to decide whether to monitor, book review, pause treatment or seek urgent advice.

Is this new or changing?

New pain, bleeding, ulcers, colour change or altered vulval architecture should be checked.

Is there a known diagnosis?

Treatment advice is safer when it is based on examination rather than assumptions.

Are symptoms affecting daily life?

Pain with sex, exercise, urination, clothing or washing is worth discussing.

Do you know red flags?

Severe pain, heavy bleeding, urinary difficulty, fever, spreading redness or non-healing ulcers need advice.

More reassuring signs

Symptoms that are mild, improving, already assessed and supported by a clear care plan are more reassuring.

Improving
Known plan
Review booked

Reasons to seek advice

Cancer Risk: There is a small but significant lifetime risk (approximately 3%) of LS transforming into Vulvar Intraepithelial Neoplasia (VIN) or invasive Squamous Cell Carcinoma. Urgent Referral: Any persistent sore, ulceration, induration, or lump.

Severe pain
Bleeding
Skin change




When to escalate

When to seek medical help

Some intimate symptoms need prompt advice because early assessment can prevent delay in the right care.

Use NHS 111 online

Severe pain or rapid worsening

Sudden severe pain, rapidly worsening symptoms or difficulty passing urine should be assessed promptly.

Bleeding, ulcers or suspicious skin change

Unexplained bleeding, non-healing ulcers, new lumps, colour change or scarring should not be ignored.

Infection signs

Fever, spreading redness, pus, feeling unwell or significant swelling needs medical advice.

Emergency symptoms

Call 999 for life-threatening symptoms such as collapse, chest pain, breathing difficulty or severe allergic reaction.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Additional clinical context

How the research was used

The Stage A reports, source guide, benchmark synthesis and payload were read before assembly. Promotional wording was softened where it risked turning a clinical question into a sales claim.

Why the page stays cautious

Intimate symptoms need precise language. The page keeps vulval skin, vaginal tissue, pelvic-floor symptoms and treatment suitability separate so the advice remains useful without overpromising.

Next step

Book a confidential consultation

A confidential consultation can review symptoms, skin changes, treatment history and whether specialist vulval or gynaecology care is appropriate.

View Research Sources (12 Sources)
• NHS — Lichen sclerosus
• British Association of Dermatologists — Lichen sclerosus in females
• BSSVD — Vulval lichen sclerosus follow-up guidance
• RCOG — Skin conditions of the vulva
• BAD guideline summary — Lichen sclerosus 2018
• Lichen Sclerosus Guide — Treatment
• Elite Aesthetics — Lichen sclerosus treatment
• Eve Clinics — Lichen sclerosus
• The Initial Management of Benign Vulval Disease Clinical Guideline - rcht.nhs.uk
• Expert comments | Optilume for anterior urethral strictures | Advice - NICE
• Interventional procedure overview of transvaginal laser therapy for urogenital atrophy - NICE
• NG23 Menopause: Evidence review B2 Managing genitourinary symptoms – breast cancer recurrence - NICE

These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 40 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.

Loading directory...